These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30648989)

  • 1. Acute Autoimmune Leukoencephalopathy Secondary to Adalimumab Therapy.
    Rukma P
    Am J Ther; 2019; 26(6):e753-e754. PubMed ID: 30648989
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
    Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
    Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
    [No Abstract]   [Full Text] [Related]  

  • 3. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
    Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
    Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
    [No Abstract]   [Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
    Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
    Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
    [No Abstract]   [Full Text] [Related]  

  • 5. Internuclear ophthalmoplegia associated with anti-TNFα medication.
    Drury J; Hickman SJ
    Strabismus; 2015; 23(1):30-2. PubMed ID: 25790247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils with ring-shaped nuclei in a patient treated with adalimumab.
    Morales-Camacho RM; Prats-Martín C
    Blood; 2019 Jan; 133(1):101. PubMed ID: 30606810
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
    Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
    [No Abstract]   [Full Text] [Related]  

  • 8. Acne conglobata induced by adalimumab.
    Balakirski G; Neis MM; Megahed M
    Eur J Dermatol; 2017 Jun; 27(3):320-321. PubMed ID: 28524046
    [No Abstract]   [Full Text] [Related]  

  • 9. Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
    Hunt WTN; Wheeler JF; Kennedy NA; Burden T; McGrath EJ
    Clin Exp Dermatol; 2021 Jan; 46(1):216-218. PubMed ID: 32931629
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab-induced porokeratosis.
    Frew JW; Parsi K
    Australas J Dermatol; 2015 Aug; 56(3):e80-1. PubMed ID: 26201378
    [No Abstract]   [Full Text] [Related]  

  • 11. Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Miranda-Bautista J; Menchén L
    Gastroenterol Hepatol; 2019 May; 42(5):306-307. PubMed ID: 30029925
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary actinomycosis coexisting with intestinal tuberculosis as a complication of adalimumab treatment for Crohn's disease.
    Aleric I; Katalinic D; Vcev A; Brinar M
    Acta Gastroenterol Belg; 2017; 80(4):544-546. PubMed ID: 29560655
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab.
    Lenti MV; Gregorini M; Borrelli de Andreis F; Rampino T; D'Ambrosio G; Verga L; Vanoli A; Mengoli C; Ravetta V; Paulli M; Di Sabatino A
    J Clin Pathol; 2021 Aug; 74(8):540-542. PubMed ID: 32820044
    [No Abstract]   [Full Text] [Related]  

  • 14. Periappendicitis during adalimumab treatment for ileocecal Crohn's disease in a 29-year-old male.
    Mizuno S; Nakazawa A; Ogawa A; Hisamatsu T; Hirose S; Tsukada N
    Clin J Gastroenterol; 2015 Jun; 8(3):134-7. PubMed ID: 26023062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediterranean spotted fever in a patient with Crohn's disease under adalimumab: First case report and review of the literature.
    Santos-Antunes J; Nunes AC; Macedo G
    Gastroenterol Hepatol; 2015; 38(6):379-80. PubMed ID: 25073681
    [No Abstract]   [Full Text] [Related]  

  • 16. Buruli (Bairnsdale) ulcer in the setting of long-term adalimumab treatment for Crohn disease.
    Freckelton J; Holt D; Sandhu M; Prideaux L; Moore GT
    Intern Med J; 2018 May; 48(5):603-604. PubMed ID: 29722190
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid in a young male during treatment with adalimumab.
    van Ammers M; Lai FYX; Abrahams T; Simpson I; Mar A
    Australas J Dermatol; 2021 Feb; 62(1):e155-e156. PubMed ID: 32981042
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic adalimumab induces peripheral corneal infiltrates: a case report.
    Matet A; Daruich A; Beydoun T; Cosnes J; Bourges JL
    BMC Ophthalmol; 2015 Jun; 15():57. PubMed ID: 26044064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
    Ferrer Bradley I; Maroto Arce N; Mora Escrig M; Hinojosa Del Val J
    Gastroenterol Hepatol; 2019; 42(6):387-388. PubMed ID: 30042000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.